Know Your Numbers Earlier: What the New Cholesterol Guidelines Mean for You

If you saw your doctor five years ago and were told your cholesterol was “fine, nothing to worry about,” it may be time to revisit that conversation. On March 13, 2026, the American College of Cardiology and the American Heart Association — along with nine other leading medical organizations — released the most significant update to cholesterol guidelines in nearly a decade. The message is clear: when it comes to heart disease, waiting is the enemy.

Why This Is a Big Deal

Heart disease is the leading cause of death in the United States, claiming a life every 34 seconds. Yet the guideline writing committee noted that 80% or more of cardiovascular disease is preventable, and elevated LDL cholesterol — often called “bad” cholesterol — is a major part of that risk.

An estimated one in four U.S. adults has high LDL cholesterol, which increases the risk of heart attack and stroke. The new guidelines are designed to catch and address that risk far earlier than before.

Start Earlier — Much Earlier

The single biggest shift in the new guidelines is the push to begin assessing and treating cholesterol risk in your 30s rather than waiting until middle age. Statin therapy is now recommended, in addition to lifestyle changes like diet and exercise, for adults as young as 30 who have an LDL cholesterol of 160 mg/dL or higher, a strong family history of premature heart disease, or a high 30-year risk of developing cardiovascular disease.

The reasoning is rooted in cumulative damage. As one leading cardiologist put it, “If you wait until people get to 55 or 60, a lot of the damage has already been done. They’ve got plaques in the coronaries, and it’s hard to undo the problem.”

The evidence base has demonstrated that people who maintain low levels of LDL cholesterol and triglycerides at earlier ages are much less likely to develop atherosclerotic disease decades later. In short, the damage accumulates silently over decades — and the best time to intervene is before it starts.

A New Test You’ve Probably Never Had

One of the most consequential changes in the new guidelines is a recommendation that every adult be tested once in their lifetime for something called lipoprotein(a), or Lp(a). Lp(a) is a genetic risk marker for heart disease that standard cholesterol panels don’t measure — and most people have never been screened for it.

Measuring Lp(a) is now strongly recommended once during an adult’s lifetime, and apolipoprotein B testing has a clear pathway toward improving risk assessment and guiding treatment. These are not exotic tests — they’re simply tools that have long existed but were underused. The new guidelines change that.

Better Tools for Calculating Your Risk

The guidelines also retire the risk calculation formula that doctors have used for the past two decades, replacing it with a more accurate tool called PREVENT — short for Predicting Risk of Cardiovascular Disease EVENTs. This calculator can project a patient’s 10-year and 30-year risk of heart disease to help guide decisions about starting medication.

The guidelines also call for wider use of coronary calcium scoring, a noninvasive scan that measures calcified plaque in the arteries, which can help doctors and patients make more informed decisions about whether medication is warranted.

What About Statins?

Cholesterol-lowering drugs known as statins remain the first-line treatment for high cholesterol. Under the new framework, medications could be considered even for patients with relatively low risk, if their overall lifetime risk profile supports it. Since generic versions are available for all major statin types, the drugs are generally affordable.

Possible side effects — including muscle pain or weakness — are real, but leading cardiologists emphasize that starting at a low dose early, rather than a high dose later, reduces those risks while still delivering the long-term benefit of keeping LDL in check over a lifetime.

Lifestyle Remains the Foundation

None of this means medication is the automatic answer. The guidelines emphasize the benefits of modifying everyday behaviors and habits, including regular physical activity, avoiding tobacco products, and healthy sleep habits. Diet and exercise remain the cornerstone of cardiac prevention — medication is the tool you reach for when lifestyle changes aren’t enough.

What You Should Do Now

If you are over 30 and haven’t had a comprehensive cholesterol conversation with your doctor recently — one that includes your family history, a discussion of Lp(a) testing, and a look at your long-term risk — now is the time to ask for one. These guidelines will almost certainly affect how your physician approaches that conversation going forward. Don’t wait for them to bring it up.